58th
EASD Annual Meeting
19 - 23 September 2022, Stockholm & Online
Final Programme: Interactive Flip Book - Downloadable PDF
Presentation Instructions: Oral - Short Oral
BEWARE OF FRAUDULENT WEBSITES!
Register only via the easd.org website for the EASD Annual Meeting 2022. For hotel bookings, we recommend using the booking platform of our official partner Interplan.
Join us for #EASD2022
We believe a hybrid congress experience ensures that the global diabetes community can benefit from the latest research and innovations in the field of diabetes and offers various options for exchange and interaction, independent of the ongoing uncertainties regarding meeting and travel regulations across the globe.
We hope to meet you in person in Stockholm in September 2022 and - to those who might not be able to travel - we look forward to welcoming you virtually!
Email scam involving Diabetologia
We have been made aware of emails in circulation that purport to come from Diabetologia inviting researchers to submit their work to the journal. The scammers go on to invite direct submission to them (ie not through our online submission system) and follow this with an acceptance letter requesting payment of processing charges before online publication. Please contact the editorial office (diabetologia-j@bristol.ac.uk) if you think you have received any such emails.
Call for Applications
EASD will hold its 28th Scientists Training Course in Maastricht, The Netherlands, from 24-28 October 2022, with the objective of promoting new talents in the field of diabetes research and fostering diabetes research in centers throughout the world.
Applications are welcome from EASD members under the age of 40. The application deadline is on 1 September 2022.
The core objective of the EASD Academy is to provide unique opportunities for development, a platform for exchange of knowledge and experience, peer-support, and interaction with the wider EASD community for early-career scientists and clinicians with an interest in diabetes research and/or clinical practice.
The EASD Academy Board invites you to visit their newly created webpages to learn more and to join the inaugural session on 20 September 2022, 17:45 - 19:15, at this year’s EASD Annual Meeting, to launch the EASD Academy.
EFSD welcomes applications for the following programme
European Foundation for the Study of Diabetes (EFSD) and Lilly European Diabetes Research Programme
Application Deadline: 1 September 2022
EFSD "New Targets for Diabetes or Obesity-related Metabolic Diseases" supported by MSD
Application deadline: 1 December 2022
New EASD e-Learning module launched
This module, which is the first in a new course on beta cell biology, explores the critical role that disrupted insulin secretion in pancreatic beta cells plays in the pathogenesis of type 2 diabetes. It looks at how research – including genome editing and stem cell research – is shedding new light on the complex intracellular triggering pathway by which healthy beta cells regulate blood glucose.
EASD 2022 Photo Mosaic
Show the global diabetes community that you will join EASD 2022! Share and comment your photo!
This photo mosaic is brought to you by Interplan and may include sponsored content.
There are many good reasons to join EASD
A discounted registration fee for the EASD Annual Meeting, a wide range of EFSD grants and fellowships and full access to Diabetologia - just to name a few.
Access your MyEASD account, review your EASD Membership status and join us or renew your existing membership.
The European Foundation for the Study of Diabetes (EFSD) was created by EASD to provide funding in all areas of diabetes research across the entire European Region. The aims of EFSD are to encourage and support groundbreaking diabetes research and to promote the next generation of leading diabetes researchers. more
Impact Factor 2020: 10.1
Diabetologia is the Journal of the EASD and publishes original clinical, translational and experimental research within the field of diabetes. We are interested in papers that convey new information or insight into any aspect of the condition, ranging from basic science to clinical applications. more
